The surface-enhanced Raman spectroscopy platform can detect amyloid beta biomarkers at ultra-low concentrations in body fluids, potentially enabling earlier diagnosis and monitoring of disease progression.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
